The Art of Storytelling in Medical Affairs: Opportunities, Challenges, and Channels
Gerd M?ller, MD, PhD, Health Economist
Purpose-driven Medical Leader in Biopharmaceuticals, passionate about improving access to Healthcare and building Trust. #MedicalAffairsEnthusiast. #MentorCoach. Final ABPI Medical Signatory experience. P&G Alumnus.
Introduction: In the complex world of the biopharmaceutical industry, storytelling is gaining increasing importance as a communication tool for Medical Affairs professionals. This narrative technique allows for effective communication of scientific findings while creating emotional connections [1].
The Significance of Storytelling: Storytelling in Medical Affairs serves to transform complex medical information into understandable and memorable narratives. According to a study by Green and Brock (2000), well-told stories can increase the persuasiveness of information and improve understanding [2]. Dr. John Medina, author of "Brain Rules," emphasizes: "The human brain processes stories 22 times more effectively than facts alone." [3]
Advantages:
Challenges and Best Practices:
Scientific Accuracy: The integrity of scientific data must be maintained. A study by Dahlstrom (2014) shows that narrative formats can influence the perception of scientific information [4].
Target Group Orientation: Stories must be tailored to the specific target audience. A study by Hinyard and Kreuter (2007) underscores the importance of adapting narratives to different target groups in healthcare [5].
Ethical Considerations: Storytelling should not be manipulative. The American Medical Association emphasizes the importance of transparency in medical communication in its ethical guidelines [6].
Regulatory Compliance: All stories must comply with applicable regulations. The FDA has strict guidelines for communicating drug information [7].
Avoiding Pitfalls:
Example of Effective Storytelling in Medical Affairs:
A good example of effective storytelling in Medical Affairs is Genentech's communication strategy for their drug Herceptin (Trastuzumab), used in the treatment of HER2-positive breast cancer [8].
Genentech utilized the story of Dr. Dennis Slamon, the researcher who played a key role in the development of Herceptin. The narrative began with Dr. Slamon's early research and his challenges in obtaining funding and support for his work. It described his tireless efforts and the many setbacks he had to overcome.
The story culminated in the successful development of Herceptin and showed the transformative effect of the drug on the lives of patients with HER2-positive breast cancer. Genentech skillfully combined this personal story with scientific data and clinical outcomes.
This storytelling was effective for several reasons:
This example demonstrates how storytelling in Medical Affairs can be used to communicate scientific innovations, build emotional connections, and simultaneously maintain the integrity of medical information [9].
Media and Communication Channels for Storytelling in Medical Affairs:
The effectiveness of storytelling in Medical Affairs can be significantly influenced by the choice of media and communication channels. Some platforms are more suitable than others for conveying complex medical narratives.
Highly Suitable Channels:
Moderately Suitable Channels:
Less Suitable Channels:
When selecting a channel, it's crucial to consider the target audience, the complexity of the story, regulatory constraints, and the desired level of engagement. A multi-channel approach, leveraging the strengths of different mediums, often proves most effective in Medical Affairs storytelling [21].
Conclusion:
Storytelling in Medical Affairs is a powerful tool that, when applied correctly, can significantly improve communication. However, it requires a careful balance between engagement, scientific integrity, and regulatory compliance. As the Genentech example shows, effective storytelling can make complex scientific concepts more accessible while creating an emotional connection with the audience. The choice of appropriate media and communication channels further enhances the impact of these narratives, allowing for more effective dissemination of crucial medical information to diverse audiences.
References: [1] Hartling, L., et al. (2010). Storytelling as a communication tool for health consumers: development of an intervention for parents of children with croup. Stories to communicate health information. BMC Pediatrics, 10(1), 64.
[2] Green, M. C., & Brock, T. C. (2000). The role of transportation in the persuasiveness of public narratives. Journal of Personality and Social Psychology, 79(5), 701-721.
[3] Medina, J. (2008). Brain Rules: 12 Principles for Surviving and Thriving at Work, Home, and School. Pear Press.
[4] Dahlstrom, M. F. (2014). Using narratives and storytelling to communicate science with nonexpert audiences. Proceedings of the National Academy of Sciences, 111(Supplement 4), 13614-13620.
[5] Hinyard, L. J., & Kreuter, M. W. (2007). Using narrative communication as a tool for health behavior change: a conceptual, theoretical, and empirical overview. Health Education & Behavior, 34(5), 777-792.
[6] American Medical Association. (2016). AMA Code of Medical Ethics. Chicago, IL: American Medical Association.
[7] U.S. Food and Drug Administration. (2018). Medical Product Communications That Are Consistent With the FDA-Required Labeling — Questions and Answers. Guidance for Industry.
[8] Genentech. (2018). The HER2 Story. Retrieved from https://www.gene.com/stories/the-her2-story
[9] Dahlstrom, M. F. (2014). Using narratives and storytelling to communicate science with nonexpert audiences. Proceedings of the National Academy of Sciences, 111(Supplement 4), 13614-13620.
[10] Lupia, A. (2013). Communicating science in politicized environments. Proceedings of the National Academy of Sciences, 110(Supplement 3), 14048-14054.
[11] Mayer, R. E. (2014). Incorporating motivation into multimedia learning. Learning and Instruction, 29, 171-173.
[12] Oerther, S., & Oerther, D. B. (2018). Pierre Bourdieu's theory of practice offers nurses a framework to uncover embodied knowledge. Nursing Philosophy, 19(3), e12208.
[13] Gallo, C. (2014). Talk like TED: The 9 public-speaking secrets of the world's top minds. St. Martin's Press.
[14] Pollock, N. R. (2019). Narrative Medicine in the International Education of Physicians. The Permanente Journal, 23.
[15] Ventola, C. L. (2014). Social media and health care professionals: benefits, risks, and best practices. Pharmacy and Therapeutics, 39(7), 491.
[16] Patel, S., Cain, R., Neailey, K., & Hooberman, L. (2015). General Practitioners' Concerns About Online Patient Feedback: Findings From a Descriptive Exploratory Qualitative Study in England. Journal of Medical Internet Research, 17(12), e276.
[17] Spinelli, M., & Dann, L. (2019). Podcasting: The audio media revolution. Bloomsbury Publishing USA.
[18] Ventola, C. L. (2011). Direct-to-consumer pharmaceutical advertising: therapeutic or toxic?. Pharmacy and Therapeutics, 36(10), 669.
[19] Maar, M. A., et al. (2016). Unpacking the Black Box: A Formative Research Approach to the Development of Theory-Driven, Evidence-Based, and Culturally Safe Text Messages in Mobile Health Interventions. JMIR mHealth and uHealth, 4(1), e10.
[20] Bergstr?m, A., & Belfrage, M. J. (2018). News in Social Media. Digital Journalism, 6(5), 583-598.
[21] Bernhardt, J. M., Mays, D., & Kreuter, M. W. (2011). Dissemination 2.0: closing the gap between knowledge and practice with new media and marketing. Journal of Health Communication, 16(sup1), 32-44.